Faraday Future Delivers First Robots in Middle East, Plans September Launches 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
CIA-Linked Investor Helped Quantum Systems Expand in US 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Add as a preferred source on Google
EMERYVILLE, Calif., April 03, 2018 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the H.C. Wainwright Global Life Sciences Investment Conference to be held April 8-10, 2018, at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
Amyris will provide an update on its business during the presentation, which is scheduled for Monday, April 9, at 5:30 a.m. Eastern Time/11:30 a.m. local Monaco time. The company will also be meeting with international investors in 1X1 meetings April 9-10. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris, the Amyris logo and No Compromise are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]
